Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission.
Konishi T, Doki N, Kishida Y, Nagata A, Yamada Y, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Konishi T, et al. Among authors: shirane s. Ann Hematol. 2019 Jul;98(7):1799-1801. doi: 10.1007/s00277-019-03668-0. Epub 2019 Mar 21. Ann Hematol. 2019. PMID: 30899981 No abstract available.
Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation.
Kurosawa S, Toya T, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Among authors: shirane s. Leuk Lymphoma. 2018 Dec;59(12):3006-3009. doi: 10.1080/10428194.2018.1441410. Epub 2018 Apr 4. Leuk Lymphoma. 2018. PMID: 29616841 No abstract available.
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.
Kurosawa S, Sekiya N, Doki N, Yaguchi T, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Among authors: shirane s. Int J Infect Dis. 2019 Dec;89:154-162. doi: 10.1016/j.ijid.2019.10.003. Epub 2019 Oct 9. Int J Infect Dis. 2019. PMID: 31605809 Free article. Review.
[Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Uchida T, Doki N, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Uchida T, et al. Among authors: shirane s. Rinsho Ketsueki. 2020;61(1):11-19. doi: 10.11406/rinketsu.61.11. Rinsho Ketsueki. 2020. PMID: 32023596 Japanese.
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation.
Kurosawa S, Doki N, Senoo Y, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Among authors: shirane s. Ann Hematol. 2020 Aug;99(8):1873-1882. doi: 10.1007/s00277-020-04090-7. Epub 2020 May 25. Ann Hematol. 2020. PMID: 32451708 Clinical Trial.
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.
Murata M, Suzuki R, Nishida T, Shirane S, Shimazu Y, Minami Y, Mori T, Doki N, Kanda Y, Uchida N, Tanaka M, Ishikawa J, Togitani K, Fukuda T, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Kiyoi H. Murata M, et al. Among authors: shirane s. Intern Med. 2020;59(16):1947-1956. doi: 10.2169/internalmedicine.4375-19. Epub 2020 Aug 15. Intern Med. 2020. PMID: 32801269 Free PMC article.
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.
Shirane S, Najima Y, Fukushima K, Sekiya N, Funata N, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Kurosawa S, Yoshifuji K, Uchida T, Inamoto K, Shingai N, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K, Horiguchi SI, Hishima T, Doki N. Shirane S, et al. J Infect Chemother. 2022 Dec;28(12):1658-1662. doi: 10.1016/j.jiac.2022.08.003. Epub 2022 Aug 10. J Infect Chemother. 2022. PMID: 35963603 Review.
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies.
Kaito S, Najima Y, Sadato D, Hirama C, Kishida Y, Nagata A, Konishi T, Yamada Y, Kurosawa S, Yoshifuji K, Shirane S, Shingai N, Toya T, Shimizu H, Haraguchi K, Kobayashi T, Harada H, Okuyama Y, Harada Y, Doki N. Kaito S, et al. Among authors: shirane s. Bone Marrow Transplant. 2024 Aug;59(8):1169-1175. doi: 10.1038/s41409-024-02311-5. Epub 2024 May 23. Bone Marrow Transplant. 2024. PMID: 38783125
81 results